{"transactions":[{"id":4630863,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T21:20:00.000Z","date":"2026-10-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.46,"value":14600.0,"ownership":{"direct":true},"balance_after":1590294,"source":{"system":"sec-edgar","filing":"0001493152-26-045772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620013/000149315226045772/ownership.xml","form_type":"4"}},{"id":4630862,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T21:20:00.000Z","date":"2026-10-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.42,"value":14200.0,"ownership":{"direct":true},"balance_after":1580294,"source":{"system":"sec-edgar","filing":"0001493152-26-045772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620013/000149315226045772/ownership.xml","form_type":"4"}},{"id":739563,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":60666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":121334,"derivative":{"underlying":"Common Stock","underlying_shares":60666},"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":739562,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":60666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."}],"balance_after":1570294,"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":739561,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1498900,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1509628,"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":934121,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:05:24.000Z","date":"2026-01-16","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.6712,"value":8356.0,"ownership":{"direct":true},"balance_after":10728,"source":{"system":"sec-edgar","filing":"0001493152-26-003078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226003078/ownership.xml","form_type":"4"}},{"id":939991,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-14T02:43:07.000Z","date":"2026-01-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.88,"value":9400.0,"ownership":{"direct":true},"balance_after":5728,"source":{"system":"sec-edgar","filing":"0001493152-26-002107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226002107/ownership.xml","form_type":"4"}},{"id":1005716,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:21:46.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the \"Plan\") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amended Form 4 is being filed to correct the previously reported grant amount of 1,538,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 1,356,700 RSUs of the previously reported grant of 1,538,700 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":182000,"derivative":{"underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001493152-25-021134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225021134/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-08"}},{"id":1021378,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:48:59.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":1538700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1538700,"derivative":{"underlying":"Common Stock","underlying_shares":1538700},"source":{"system":"sec-edgar","filing":"0001493152-25-017481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017481/ownership.xml","form_type":"4"}},{"id":1046761,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:41.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":64400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."}],"balance_after":64400,"derivative":{"underlying":"Common Stock","underlying_shares":64400},"source":{"system":"sec-edgar","filing":"0001493152-25-012693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012693/ownership.xml","form_type":"4"}},{"id":1354088,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-11-22T21:00:10.000Z","date":"2024-11-21","kind":"exercise","planned":false,"acquired":true,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."}],"balance_after":728,"source":{"system":"sec-edgar","filing":"0001493152-24-047363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224047363/ownership.xml","form_type":"4"}},{"id":1425176,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:07:40.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean August 20, 2024."}],"balance_after":50000,"derivative":{"exercise_price":0.344,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-022000","document":"form4-08222024_080837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924022000/form4-08222024_080837.xml","form_type":"4"}},{"id":1454489,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-07-16T00:10:24.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":2100,"derivative":{"exercise_price":4.49,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001493152-24-027907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224027907/ownership.xml","form_type":"4"}},{"id":1481934,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-06-13T01:40:23.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":true,"shares":340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":340,"source":{"system":"sec-edgar","filing":"0001493152-24-023612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224023612/ownership.xml","form_type":"4"}},{"id":1499004,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-05-29T19:47:14.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.863,"value":4863.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.863 on May 28, 2024."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-24-021777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224021777/ownership.xml","form_type":"4"}},{"id":1663791,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-01T13:30:23.000Z","date":"2024-01-31","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.605,"value":6050.0,"ownership":{"direct":false,"nature":"By Reporting Person's Defined Benefit Plan"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock of Issuer at a price per share of $0.605 on January 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock of Issuer at a price per share of $0.605 on January 31, 2024."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001493152-24-004565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224004565/ownership.xml","form_type":"4"}},{"id":1730223,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-11-24T21:00:18.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-23-042660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042660/ownership.xml","form_type":"4"}},{"id":1730222,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-11-24T21:00:18.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A."}],"balance_after":5820,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-23-042660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042660/ownership.xml","form_type":"4"}},{"id":1771445,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-29T13:25:18.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.54,"value":10800.0,"ownership":{"direct":false,"nature":"By Reporting Person's Defined Benefit Plan"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 20,000 shares of Common Stock of Issuer at a price per share of $0.54 on September 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 20,000 shares of Common Stock of Issuer at a price per share of $0.54 on September 27, 2023."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-23-034756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223034756/ownership.xml","form_type":"4"}},{"id":1776117,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-20T21:54:09.000Z","date":"2023-09-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean September 19, 2023."}],"balance_after":25000,"derivative":{"exercise_price":0.8,"expiration_date":"2033-09-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-050195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123050195/doc4.xml","form_type":"4"}},{"id":1817771,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T22:02:17.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":59405,"price":1.01,"value":59999.05,"ownership":{"direct":true},"balance_after":59405,"source":{"system":"sec-edgar","filing":"0001209191-23-044285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123044285/doc4.xml","form_type":"4"}},{"id":1857102,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-13T22:43:59.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":12160,"derivative":{"exercise_price":1.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-23-021129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021129/ownership.xml","form_type":"4"}},{"id":1857101,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T22:43:59.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":5100,"derivative":{"underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001493152-23-021129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021129/ownership.xml","form_type":"4"}},{"id":2247340,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T21:14:48.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. \"Date of Grant\" shall mean June 1, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-033633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122033633/doc4.xml","form_type":"4"}},{"id":2374545,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-24T22:08:08.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant.  \"Date of Grant\" shall mean February 23, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-02-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-012749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122012749/doc4.xml","form_type":"4"}},{"id":2404155,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T23:23:21.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":48340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period."}],"balance_after":48340,"derivative":{"exercise_price":2.32,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":48340},"source":{"system":"sec-edgar","filing":"0001209191-22-008581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919122008581/doc4.xml","form_type":"4"}},{"id":2660368,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T18:17:10.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":10221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365."}],"balance_after":134728,"source":{"system":"sec-edgar","filing":"0001179110-21-006874","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911021006874/edgar.xml","form_type":"4"}},{"id":2688798,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-01T23:29:29.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting.  \"Date of Grant\" shall mean May 28, 2021."}],"balance_after":20000,"derivative":{"exercise_price":35.54,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-021413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321021413/doc4.xml","form_type":"4"}},{"id":2735746,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:56:25.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":4406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 162,069 shares of LBS common stock for $0.73 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests according to the following schedule: 25% of the shares underlying the option vests on grant date and the remaining 75% vests in three equal quarterly installments thereafter beginning on September 30, 2020."}],"balance_after":4406,"derivative":{"exercise_price":26.85,"expiration_date":"2030-07-10","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001209191-21-029081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029081/doc4.xml","form_type":"4"}},{"id":2735745,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:56:25.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":10203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for a stock option to acquire 375,250 shares of common stock of Leading BioSciences, Inc. (\"LBS\") for $1.12 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the \"Merger\").  Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock.  In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested in four equal quarterly installments from June 30, 2019."}],"balance_after":10203,"derivative":{"exercise_price":41.2,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":10203},"source":{"system":"sec-edgar","filing":"0001209191-21-029081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029081/doc4.xml","form_type":"4"}},{"id":3104051,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T21:52:12.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":26956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 26,956 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.  The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 26,956 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.  The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 26,956 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.  The restricted stock units vest on the 12 month anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 17, 2020, issuer granted to the reporting person 26,956 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.  The restricted stock units vest on the 12 month anniversary of the grant date."}],"balance_after":124507,"source":{"system":"sec-edgar","filing":"0001179110-20-007661","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911020007661/edgar.xml","form_type":"4"}},{"id":3106871,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T00:56:32.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the Date of Grant.  \"Date of Grant\" shall mean June 15, 2020."}],"balance_after":30000,"derivative":{"exercise_price":18.9,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-016938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924320016938/doc4.xml","form_type":"4"}},{"id":3478573,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T21:48:18.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":18086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 21, 2019, issuer granted to the reporting person 18,086 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 21, 2019, issuer granted to the reporting person 18,086 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 21, 2019, issuer granted to the reporting person 18,086 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."}],"balance_after":64519,"source":{"system":"sec-edgar","filing":"0001179110-19-008111","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911019008111/edgar.xml","form_type":"4"}},{"id":3596816,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-14T00:06:29.000Z","date":"2019-03-12","kind":"purchase","acquired":true,"shares":4000,"price":2.4725,"value":9890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.45 to $2.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":46433,"source":{"system":"sec-edgar","filing":"0001179110-19-003808","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911019003808/edgar.xml","form_type":"4"}},{"id":3856545,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T01:19:09.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":20492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 20,492 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 20,492 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 30, 2018, issuer granted to the reporting person 20,492 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The restricted stock units vest on the earlier of (i) the 12 month anniversary of the grant date and (ii) the date of issuer's next annual meeting of stockholders."}],"balance_after":42433,"source":{"system":"sec-edgar","filing":"0001179110-18-010085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911018010085/edgar.xml","form_type":"4"}},{"id":3961613,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of the issuer's private placement of shares of its Series E Convertible Preferred Stock and warrants to purchase shares of its common stock (the \"Offering\"), which occurred on April 16, 2018, the issuer and the reporting person agreed that the issuer would satisfy all accrued and unpaid fees owed by the issuer to the reporting person for services as a member of the issuer's Board of Directors prior to January 1, 2018 by the issuance by the issuer to the reporting person of 18 shares of Series E Preferred Stock and warrants to purchase 135,000 shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants expire on the five year anniversary of the closing of the Offering."}],"balance_after":135000,"derivative":{"exercise_price":0.55,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001493152-18-005445","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005445/form4.xml","form_type":"4"}},{"id":3961612,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":18,"price":5000,"value":90000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of the issuer's private placement of shares of its Series E Convertible Preferred Stock and warrants to purchase shares of its common stock (the \"Offering\"), which occurred on April 16, 2018, the issuer and the reporting person agreed that the issuer would satisfy all accrued and unpaid fees owed by the issuer to the reporting person for services as a member of the issuer's Board of Directors prior to January 1, 2018 by the issuance by the issuer to the reporting person of 18 shares of Series E Preferred Stock and warrants to purchase 135,000 shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each outstanding share of Series E Preferred Stock shall be converted into common stock on the earliest to occur of: (i) any date more than 30 trading days after the closing of the Offering that the closing price of the common stock on each of the 30 days immediately prior to such conversion exceeds $5.00; (ii) the three year anniversary of the closing of the Offering; and (iii) the date on which the holders of a majority of the outstanding shares of Series E Preferred Stock elect to convert all of the outstanding shares of Series E Preferred Stock."}],"balance_after":18,"derivative":{"exercise_price":0.5,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001493152-18-005445","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005445/form4.xml","form_type":"4"}},{"id":4115590,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-03T18:55:54.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2018, and options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2019."}],"balance_after":3800,"derivative":{"exercise_price":1.56,"expiration_date":"2023-01-03","underlying":"common stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001587074-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000158707418000004/primary_doc.xml","form_type":"4"}},{"id":4272440,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-26T22:58:10.000Z","date":"2017-04-25","kind":"grant","acquired":true,"shares":28090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments."}],"balance_after":28090,"derivative":{"exercise_price":1.98,"exercise_date":"2018-04-25","expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":28090},"source":{"system":"sec-edgar","filing":"0001179110-17-009624","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911017009624/edgar.xml","form_type":"4"}},{"id":4272439,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-26T22:58:10.000Z","date":"2017-04-25","kind":"grant","acquired":true,"shares":18939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":21941,"source":{"system":"sec-edgar","filing":"0001179110-17-009624","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000117911017009624/edgar.xml","form_type":"4"}},{"id":4506168,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-01-04T18:27:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2017 and options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2018."}],"balance_after":81000,"derivative":{"exercise_price":0.17,"expiration_date":"2022-01-03","underlying":"common stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001493152-17-000149","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315217000149/form4.xml","form_type":"4"}},{"id":4518526,"issuer":{"id":4720,"kind":"organization","name":"Alphatec Holdings, Inc.","symbol":"ATEC"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NQ Stock Option","published_at":"2016-12-16T18:16:35.000Z","date":"2016-12-12","kind":"grant","acquired":true,"shares":3303,"price":4.43,"value":14632.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully vested as of the grant date."}],"balance_after":6569,"derivative":{"exercise_price":4.43,"exercise_date":"2016-12-12","expiration_date":"2026-12-12","underlying":"Common Sock","underlying_shares":3303},"source":{"system":"sec-edgar","filing":"0001350653-16-000123","document":"wf-form4_148191217752978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350653/000135065316000123/wf-form4_148191217752978.xml","form_type":"4"}},{"id":4551899,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2016-11-17T17:31:11.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":0.1,"exercise_date":"2016-11-15","expiration_date":"2021-11-15","underlying":"Common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-16-015244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315216015244/form4.xml","form_type":"4"}}]}